International Journal of Endocrinology / 2014 / Article / Tab 3

Research Article

Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity

Table 3

Demographic characteristics and clinical response: Asian versus non-Asian groups.

AsianNon-Asian Test statistics

Age (years)61.6 ± 10.362.3 ± 8.3;
Weight (kg)69.0 (60.2–77.6)89.0 (77.5–100.1);
Body mass index (kg/m2)25.6 (24.0–27.5)31.6 (28.2–34.4);
Diabetes duration (years)13.7 ± 5.811.7 ± 5.7;
Duration on triple therapy (months)4.6 (3.7–6.4)4.5 (3.5–7.2);
Baseline HbA1c
 (%)8.1 (7.6–8.7)8.3 (7.8–8.9);
 (mmol/mol) 65 (60–72)67 (62–74)
Change in weight from baseline (kg)−0.7 ± 1.6 −1.0 ± 2.4;
Change in HbA1c from baseline (%)−1.00 (0.6–1.3)−0.90 (0.4–1.6);
Patients achieving a given HbA1c
 <7% (53 mmol/mol)39.025.6;
 <8% (64 mmol/mol)90.276.9;

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.